Milpitas, California-based diabetes management company Bigfoot Biomedical has raised $35.5 million in Series A funding in a round with participation from Cormorant Asset Management, Senvest Capital and Visionnaire Ventures. The funding will be used to further develop the company’s connected, automated insulin delivery service.
Bigfoot bills itself as “drawing a circle around everything that it...
As we take a look at the devices that received FDA clearance in 2016's third quarter, we're also considering that the last few months have been a time of change at the Food and Drug Administration, as regulators are beginning to make updates in their system to accomodate all the digital health tools we're seeing.
In June, the FDA offered up a draft guidance document designed to help medical...
In rural Mississippi, where almost 65 percent of the state's counties are more than a 40 minute drive from specialty care and 68 percent of the providers are in urban areas even though 64 percent of the patients are in rural areas, telehealth takes on an added importance.
Michael Adcock, and administrator at the University of Mississippi Medical Center's Center for Telehealth spoke at the Pop...
Digital patient engagement company HealthPrize Technologies has partnered with Walgreens to offer its medication adherence platform on the drugstore chain’s website. The program will be offered to patients filling certain brand-name prescriptions for chronic conditions, starting with diabetes and eventually expanding to others. The platform will be web-based, but Walgreen's site is optimized for...
A number of pieces of interesting health tech news came out of the 76th Annual Scientific Sessions of the American Diabetes Association, held this weekend in New Orleans. Here’s a roundup of the highlights.
Updated 6/15/2016 to include some more news items.
IBM’s Medtronic partnership gets a name. Information has been trickling out about Medtronic’s collaboration with IBM Watson Health that was...
Next month the FDA is hosting a public advisory committee meeting to discuss a change to the intended use of Dexcom's G5 Mobile Continuous Glucose Monitoring System (CGM) device that would allow the company to market the G5 as a CGM patients can base treatment decisions on.
Currently, Dexcom's CGMs are considered adjunctive devices, which means they carry an asterisk that notes they are intended...
In late 2014, MobiHealthNews reported that Atlanta-based diabetes management company Rimidi was piloting its software in a 129-patient RCT with Desert Oasis Healthcare, part of Heritage California ACO, a pioneer ACO. Now the company has made public some of the preliminary results from the ongoing study, showing that patients who used Rimidi’s intervention dropped their HbA1c by 2 percentage...
The diabetes management space has long held a commanding lead as the most popular target for mobile health developers, according to a new blog post from Research2Guidance based on their mHealth App Developer Economics report, for which the research firm surveyed 5,000 developers.
"In each survey we have conducted since 2010, diabetes has consistently been considered the therapy field offering the...
Livongo Health, the diabetes management startup launched last year by former Allscripts CEO Glen Tullman, will roll out its platform to a large group of New Yorkers via the Mount Sinai health system. The program, which has already been available to Mount Sinai employees, will now start to be available to patients in the Mount Sinai network.
"With several hundred thousand individuals covered...
This week Accenture published the results from its annual Accenture Technology Vision 2015 survey, which includes responses from more than 1,000 executives in developed and developing markets across various industries, including more than 100 from the life sciences.
Some 70 percent of the life sciences executives surveyed said that the next generation of digital health platforms will not be led...
